SANTHERA PHARMACEUTICALS (SCHWEIZ) AG;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
发明人:
MEIER THOMAS,BIELEKOVA BIBIANA,MCFARLAND HENRY F.,MEIER Thomas,BIELEKOVA Bibiana,MCFARLAND Henry F.
申请号:
SI200931234
公开号:
SI2424513T1
申请日:
2009.12.18
申请国别(地区):
SI
年份:
2015
代理人:
摘要:
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent.